Post-transplant anemia and associated risk factors
the impact of steroid-free therapy
Keywords:
Anemia, Kidney transplantation, Steroids, Risk, Therapy [subheading]Abstract
CONTEXT AND OBJECTIVE: The prevalence of post-renal transplant anemia (PTA) reported in the literature is variable and several factors contribute towards its pathophysiology. This study aimed to investigate the prevalence of PTA, its associated risk factors and the impact of therapy without steroids. DESIGN AND SETTING: Retrospective cohort study in a renal transplantation unit at a tertiary hospital. METHODS: Anemia was defined as hemoglobin (Hb) < 12 g/dl in female adult recipients and < 13 g/dl in males. Donor and recipient age and gender, type of donor, creatinine, delayed graft function, acute rejection, use of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) and therapy without steroids were investigated as risk factors for PTA through multivariate logistical regression analysis. RESULTS: Evaluations were performed on 258 recipients (mean age: 38.8 years; 60.5% males; 35.7% did not receive steroids). Anemia was diagnosed in 38% of the patients (at the sixth month, M6), 28% (M12), 32% (M24) and 45% (at last follow up). Donor age > 50 years was associated with greater risks of PTA at M6 (odds ratio (OR) = 4.68) and M24 (OR = 6.57), as well as with therapy without steroids at M6 (OR = 2.96). Delayed graft function was independently associated with PTA at M6 (OR = 3.66) and M12 (OR = 2.85). CONCLUSION: The lowest prevalence of PTA was observed between M9 and M24 after renal transplantation. Delayed graft function, donor age and therapy without steroids were the most important factors associated with PTA.
Downloads
References
Vanrenterghem Y, Ponticelli C, Morales JM, et al. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant. 2003;3(7):835-45.
Yorgin PD, Belson A, Sanchez J, et al. Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis. 2002;40(6):1306-18.
Ponticelli C, Villa M. Role of anaemia in cardiovascular mortality and mor- bidity in transplant patients. Nephrol Dial Transplant. 2002;17 Suppl 1:41-6.
Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol. 1996;7(1):158-65.
Vanrenterghem Y. Anaemia after renal transplantation. Nephrol Dial Transplant. 2004;19 Suppl 5:V54-58.
Afzali B, Al-Khoury S, Shah N, et al. Anemia after renal transplantation. Am J Kidney Dis. 2006;48(4):519-36.
Kasiske BL, Vazquez MA, Harmon WE, et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol. 2000;11 Suppl 15:S1-86.
Winkelmayer WC, Chandraker A. Posttransplantation anemia: management and rationale. Clin J Am Soc Nephrol. 2008; 3 Suppl 2:S49-55.
Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int. 2004;66(2):753-60.
Nurko S. Anemia in chronic kidney disease: causes, diagnosis, treatment. Cleve Clin J Med. 2006;73(3):289-97.
Chapman JR, O’Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol. 2005;16(10):3015-26.
Winkelmayer WC, Chandraker A, Alan Brookhart M, Kramar R, Sunder-Plassmann G. A prospective study of anaemia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant. 2006;21(12):3559-66.
De Maria R, Zeuner A, Eramo A, et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature. 1999;401(6752):489-93.
Associação Brasileira de Transplante de Órgãos. Registro Brasileiro de Transplantes 10 anos. Available from: http://www.abto.org.br/ abtov03/Upload/file/RBT/RBT_10_Anos/RBT_10anos_2006.pdf. Accessed in 2013 (Feb 13).
Shibagaki Y, Shetty A. Anemia is common after kidney transplantation, especially among African Americans. Nephrol Dial Transplant. 2004;19(9):2368-73.
Yorgin PD, Scandling JD, Belson A, et al. Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem? Am J Transplant. 2002;2(5):429-35.
Chadban SJ, Baines L, Polkinghorne K, et al. Anemia after kidney transplantation is not completely explained by reduced kidney function. Am J Kidney Dis. 2007;49(2):301-9.
Saito S, Fujiwara T, Sakagami K, Matsuno T, Tanaka N. Anemia following renal transplantation. Transplant Proc. 1998;30(7):3025-6.
Chhabra D, Grafals M, Skaro AI, Parker M, Gallon L. Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection. Clin J Am Soc Nephrol. 2008;3(4):1168-74.
Lorenz M, Kletzmayr J, Perschl A, et al. Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol. 2002;13(3):794-7.
Kim HC, Park SB, Han SY, Whang EA. Anemia following renal transplantation. Transplant Proc. 2003;35(1):302-3.
Unal A, Sipahioglu MH, Akcakaya M, et al. An underappreciated problem in renal transplant recipients: anemia. Transplant Proc. 2008;40(5):1399-403.
Shah N, Al-Khoury S, Afzali B, et al. Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors. Transplantation. 2006;81(8):1112-8.
Mahmud SN, Aziz R, Ahmed E, et al. Anemia characteristics after renal transplantation. Transplant Proc. 2002;34(6):2428.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266.
Valderrábano F, Hörl WH, Jacobs C, et al. European best practice guidelines 1-4: evaluating anemia and initiating treatment. Nephrol Dial Transplant. 2000;15 Suppl 4:8-14.
Turkowski-Duhem A, Kamar N, Cointault O, et al. Predictive factors of anemia within the first year post renal transplant. Transplantation. 2005;80(7):903-9.
Sun CH, Ward HJ, Paul WL, et al. Serum erythropoietin levels after renal transplantation. N Eng J Med. 1989;321(3):151-7.
Mix TC, Kazmi W, Khan S, et al. Anemia: a continuing problem following kidney transplantation. Am J Transplant. 2003;3(11):1426-33.
van Dullemen HM, Luykx-de Bakker S, Hillen PH, et al. Inhibitors of recombinant human erythropoietin in chronic renal failure. Neth J Med. 1992;41(1-2):56-63.
Molnar MZ, Mucsi I, Macdougall IC, et al. Prevalence and management of anaemia in renal transplant recipients: data from ten European centres. Nephron Clin Pract. 2011;117(2):c127-34.
Choukroun G, Deray G, Glotz D, et al. Incidence et prise en charge de l’anémie en transplantation rénale: une étude observationnelle française [Incidence and management of anemia in renal transplantation: an observational-French study]. Nephrol Ther. 2008;4(7):575-83.
Levin A, Hemmelgarn B, Culleton B, et al. Guidelines for the management of chronic kidney diseases. CMAJ. 2008;179(11):1154-62.
Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet. 2004;364(9447):1814-27.
Peeters P, Terryn W, Vanholder R, Lameire N. Delayed graft function in renal transplantation. Curr Opin Crit Care. 2004;10(6):489-98.
Martinez F, Kamar N, Pallet N, et al. High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. Am J Transplant. 2010;10(7): 1695-700.
Rajab A, Pelletier RP, Henry ML, Ferguson RM. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression. Clin Transplant. 2006;20(5):537-46.
Rajab A, Pelletier RP, Ferguson RM, et al. Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients. Transplantation. 2007;84(9):1131-7.
Khwaja K, Asolati M, Harmon J, et al. Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients. Am J Transplant. 2004;4(6):980-7.
Kandaswamy R, Melancon JK, Dunn T, et al. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis. Am J Transplant. 2005;5(6):1529-36.
Vincenti F, Schena FP, Paraskevas S, et al. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplantation recipients. Am J Transplant. 2008;8(2):307-16.
Golde DW, Bersch N, Cline MJ. Potentiation of erythropoiesis in vitro by dexamethasone. J Clin Invest. 1976;57(1):57-62.
Dainiak N, Hoffman R, Ritchey AK, Floyd V, Callahan M. In vitro steroid sensitivity testing: a possible means to predict response to therapy in primary hypoproliferative anemia. Am J Hematol. 1980;9(4):401-12.
Billat CL, Felix JM, Jacquot RL. In vitro and in vivo regulation of hepatic erythropoiesis by erythropoietin and glucocorticoids in the rat fetus. Exp Hematol. 1982;10(1):133-40.
Amylon MD, Perrine SP, Glader BE. Prednisone stimulation of erythropoiesis in leukemic children during remission. Am J Hematol. 1986;23(2):179-81.
von Lindern M, Zauner W, Mellitzer G, et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood. 1999;94(2):550-9.
Guitard J, Ribes D, Kamar N, et al. Predictive factors for anemia six and twelve months after orthotopic liver transplantation. Transplantation. 2006;81(11):1525-31.
Jones H, Talwar M, Nogueira JM, et al. Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis. Transplantation. 2012;93(9):923-8.
Winkelmayer WC, Kewalramani R, Rutstein M, et al. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol. 2004;15(5):1347-52.
Marathias KP, Agroyannis B, Mavromoustakos T, Matsoukas J, Vlahakos DV. Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Curr Top Med Chem. 2004;4(4):483-6.
Chua MS, Barry C, Chen X, Salvatierra O, Sarwal MM. Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays. Am J Transplant. 2003;3(1):17-22.
Besarab A, Caro J, Jarrell BE, Francos G, Erslev AJ. Dynamics of erythropoiesis following renal transplantation. Kidney Int. 1987;32(4):526-36.
